SCHEMBL16352619

SCHEMBL16352619

C[Si](C)(C)c1ccc2c(-c3cccc4ccccc34)c3ccccc3c(-c3ccccc3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ESR1 P03372 4/20 0.39
▸ ESR2 Q92731 3/20 0.39
▸ DHFR P00374 1/20 0.38
▸ ENPP1 P22413 2/20 0.37
▸ ENPP3 O14638 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12023379 1.00 ALDH1A1 (0.42) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL16352625 1.00 ALDH1A1 (0.42) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL126429 0.97 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL17935585 0.97 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL126261 0.97 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL26761119 0.94 ENPP1 (0.43) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL17935584 0.93 ENPP1 (0.45) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL17934708 0.93 ENPP1 (0.45) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL4084177 0.93 DHFR (0.43) ALDH1A1MAPTKDM4ETP53HPGD
SCHEMBL4079264 0.93 DHFR (0.43) ALDH1A1MAPTKDM4ETP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10804467-B2 Method of manufacturing organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2020-10-13 — — US disclosed
US-10333071-B2 Organic light emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2019-06-25 — — US disclosed
US-20180130949-A1 METHOD OF MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-10 — — US disclosed
US-20180130949-A1 METHOD OF MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-10 — — US disclosed
US-9673400-B2 Amine-based compound and organic light-emitting diode including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-06 — — US disclosed
US-9673400-B2 Amine-based compound and organic light-emitting diode including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-06 — — US disclosed
US-20170117478-A1 ORGANIC LIGHT EMITTING DEVICE SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2017-04-27 — — US disclosed
US-20170117478-A1 ORGANIC LIGHT EMITTING DEVICE SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2017-04-27 — — US disclosed
US-20140374717-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD (KR) 2014-12-25 — — US disclosed
US-20140374717-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170117478-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, ELOVL1, LAGE3 ALDH1A1 67/4885MAPT 916/4885KDM4E 788/4885
US-10333071-B2 Organic light emitting device CRY2, ELOVL1, LAGE3 ALDH1A1 67/4885MAPT 916/4885KDM4E 788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback